• Latest Posts

Replay Bio launches HSV gene therapy company to target retinal eye disease

New Replay HSV gene therapy company Telaria to focus on skin diseases

Replay targets genetic brain disorders with new gene therapy company, Kaleibe

FDA clears T-Cell receptor natural killer cell therapy for sarcoma

Beyond Biotech podcast 35: Rare Disease Day


Syena created to deliver first-in-class TCR-NK cell therapy

Replay receives $1.5M grant for hypoimmunogenic technology platform